TFC Financial Management’s United Therapeutics UTHR Stock Holding History

TFC Financial Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542	Hold	1	–	–	﹤0.01%	747
2026 Q1	$593	Hold	1	–	–	﹤0.01%	680
2025 Q4	$488	Hold	1	–	–	﹤0.01%	706
2025 Q3	$420	Hold	1	–	–	﹤0.01%	740
2025 Q2	$288	Hold	1	–	–	﹤0.01%	739
2025 Q1	$309	Hold	1	–	–	﹤0.01%	704
2024 Q4	$353	Hold	1	–	–	﹤0.01%	707
2024 Q3	$359	Hold	1	–	–	﹤0.01%	708
2024 Q2	$319	Buy	+1	New	+$265	﹤0.01%	692

Other funds holding UTHR

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

TFC Financial Management's UTHR Position: Q2 2026 in Review

TFC Financial Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 1 share worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #747.

TFC Financial Management first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $593 in Q1 2026. 354 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

TFC Financial Management held 1 share of United Therapeutics worth $542 as of Q2 2026.
TFC Financial Management left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #747 holding.
TFC Financial Management first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
TFC Financial Management's United Therapeutics position peaked at $593 in Q1 2026.
354 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.